Teprenone ameliorates diclofenac-induced small intestinal injury via inhibiting protease activated receptors 1 and 2 activity

References

• Carneiro-Lobo, T.C., et al., 2014. Expression of tissue factor signaling pathway elements correlates with the production of vascular endothelial growth factor and interleukin-8 in human astrocytoma patients. Oncology reports, 31 (2), 679–686.
   PubMed Web of Science ®Google Scholar
• Amadesi, S., and Bunnett, N., 2004. Protease-activated receptors: protease signaling in the gastrointestinal tract. Current opinion in pharmacology, 4 (6), 551–556.
   PubMed Web of Science ®Google Scholar
• Bjarnason, I., et al., 1988. Clinicopathological features of nonsteroidal antiinflammatory drug-induced small intestinal strictures. Gastroenterology, 94 (4), 1070–1074.
   PubMed Web of Science ®Google Scholar
• Brady, R.R., et al., 2011. c-Src dependency of NSAID-induced effects on NF-κB-mediated apoptosis in colorectal cancer cells. Carcinogenesis, 32 (7), 1069–1077.
   PubMed Web of Science ®Google Scholar
• Brunelli, C., et al., 2012. The non-steroidal anti-inflammatory drug indomethacin activates the eIF2α kinase PKR, causing a translational bl-ock in human colorectal cancer cells. Biochemical journal, 443 (2), 379–386.
   PubMed Web of Science ®Google Scholar
• Chao, G., and Zhang, S., 2012. Therapeutic effects of muscovite to non-steroidal ant-inflammatory drug-induced smallintes tinal disease. International journal of pharmaceutics, 436 (1–2), 154–160.
   PubMed Web of Science ®Google Scholar
• Chen, M.Y., et al., 2011. Expression of protease activated receptor 2 and mast cell distribution in small intestine of rats with non steroidal anti-inflammatory drugs intestinal injury. Chinese journal of medicine, 91 (21), 1502–1505.
   Google Scholar
• Chin, A.C., et al., 2003. Proteinase-activated receptor 1 activation induces epithelial apoptosis and increases intestinal permeability. Proceedings of the national academy of sciences, 100 (19), 11104–11109.
   PubMed Web of Science ®Google Scholar
• Chin, A.C., et al., 2008. Neutrophil-mediated activation of epithelial protease-activated receptors-1 and -2 regulates barrier function and transepithelial migration. The journal of immunology, 181 (8), 5702–5710.
   PubMed Web of Science ®Google Scholar
• Chiu, C.J., et al., 1970. Intestinal mucosal lesion in low-flow states. I. A morphological, hemodynamic, and metabolicreappraisal. Archives of surgery, 101 (4), 478–483.
   PubMedGoogle Scholar
• Derry, S., and Loke, Y.K., 2000. Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis. BMJ (clinical research ed.), 321 (7270), 1183–1187.
   PubMed Web of Science ®Google Scholar
• Endo, H., et al., 2010. Exogenous luminal nitric oxide exposure accelerates columnar transformation of rat esophagus. International journal of cancer, 127 (9), 2009–2019.
   PubMed Web of Science ®Google Scholar
• Fornai, M., et al., 2020. Role of proteinase-activated receptors 1 and 2 in nonsteroidal anti-inflammatory drug enteropathy. Pharmacological reports, 72 (5), 1347–1357.
   PubMed Web of Science ®Google Scholar
• Grosser, T., Smyth, E., and Fitzgerald, G. A., 2011. Anti-inflammatory, antipyeretic and analgesic agents; pharmacotherapy of gout. In: L.L. Brunton, B.A. Chabner, B.C. Knollmann, eds. Goodman and Gilman’s the pharmacological basis of therapeutics. 12th ed. New York: McGraw Hill, 959–1004.
   Google Scholar
• Henry, D.A., 1988. Side-effects of non-steroidal antiinflammatory drugs. Baillière’s clinical rheumatology, 2 (2), 425–454.
   PubMedGoogle Scholar
• Hyun, E., et al., 2010. Contribution of bone marrow-derived cells to the pro-inflammatory effects of protease-activatedreceptor-2 in colitis. Inflammation research, 59 (9), 699–709.
   PubMed Web of Science ®Google Scholar
• Inoue, T., et al., 2014. Amelioration of small bowel injury by switching from nonselective nonsteroidal anti-inflammatorydrugs to celecoxib in rheumatoid arthritis patients: a pilot study. Digestion, 89 (2), 124–132.
   PubMed Web of Science ®Google Scholar
• Ishihara, M., et al., 2014. Risk factors of symptomatic NSAID-induced small intestinal injury and diaphragm disease. Alimentary pharmacology & therapeutics, 40 (5), n/a–547.
   Web of Science ®Google Scholar
• Iwai, T., et al., 2011. Protective effect of geranylgeranylacetone against loxoprofen sodium-induced small intestinallesions in rats. European journal of pharmacology, 652 (1–3), 121–125.
   PubMed Web of Science ®Google Scholar
• Kawabata, A., 2003. Gastrointestinal functions of proteinase-activated receptors. Life sciences. 74 (2–3), 247–254.
   PubMed Web of Science ®Google Scholar
• Kuroda, M., et al., 2006. Lansoprazole, a proton pump inhibitor, reduces the severity of indomethacin-induced ratenteritis. International journal of molecular medicine. 17 (1), 89–93.
   PubMed Web of Science ®Google Scholar
• Li, S., et al., 2015. Intestinal mucosal injury induced by tryptase-activated protease-activated receptor 2 requires β-arrestin-2 in vitro. Molecular medicine reports, 12 (5), 7181–7187.
   PubMed Web of Science ®Google Scholar
• Lü, B., et al., 2008. Effects of teprenone on expression of heat shock protein 70 and c-fos in stomach following prednisolone ingestion: experiment with rats. Zhonghua Yi xue Za zhi, 88 (4), 220–224.
   PubMedGoogle Scholar
• Marshall, T.A., Pai, S., and Reddy, P.P., 1985. Intestinal perforation following enteral administration of indomethacin. Journal of pediatrics, 107 (3), 484–485.
   PubMed Web of Science ®Google Scholar
• Morris, A.J., et al., 1991. Enteroscopic diagnosis of small bowel ulceration in patients receiving non-steroidal anti-inflammatory drugs. The lancet, 337 (8740), 520.
   PubMed Web of Science ®Google Scholar
• Nagano, Y., et al., 2012. Bisphosphonate-induced gastrointestinal mucosal injury is mediated by mitochondrialsuperoxide production and lipid peroxidation. J clin biochem nutr, 51 (3), 196–203.
   PubMed Web of Science ®Google Scholar
• Nagata, N., et al., 2014. Lower GI bleeding risk of nonsteroidal anti-inflammatory drugs and antiplatelet drug use aloneand the effect of combined therapy. Gastrointestinal endoscopy, 80 (6), 1124–1131.
   PubMed Web of Science ®Google Scholar
• Scarpignato, C., 2008. NSAID-induced intestinal damage: are luminal bacteria the therapeutic target? Gut, 57 (2), 145–148.
   PubMed Web of Science ®Google Scholar
• Scheiman, J.M., 2016. NSAID-induced gastrointestinal injury: a focused update for clinicians. Journal of clinical gastroenterology, 50 (1), 5–10.
   PubMed Web of Science ®Google Scholar
• Shi, S., et al., 2014. Increased gap density predicts weakness of the epithelial barrier in vivo by confocal laserendomicroscopy in indomethacin-induced enteropathy. Digestive diseases and sciences, 59 (7), 1398–1405.
   PubMed Web of Science ®Google Scholar
• Sostres, C., Gargallo, C.J., and Lanas, A., 2013. Nonsteroidal anti-inflammatory drugs and upper and lower gastrointestinal mucosal damage. Arthritis research & therapy, 15 (Suppl 3), S3.
   PubMed Web of Science ®Google Scholar
• Takeuchi, K., et al., 2014. Effect of rebamipide on gastric bleeding and ulcerogenic responses induced by aspirin plusclopidogrel under stimulation of acid secretion in rats. Journal of gastroenterology and hepatology, 29 (Suppl 4), 37–46.
   PubMedGoogle Scholar
• Umegaki, E., et al., 2014. Geranylgeranylacetone, a gastromucoprotective drug, protects against NSAID-inducedesophageal, gastroduodenal and small intestinal mucosal injury in healthy subjects: a prospective randomized study involving a comparison with famotidine. Internal medicine (medicine), 53 (4), 283–290.
   PubMed Web of Science ®Google Scholar
• Wallace, J.L., et al., 2011. Proton pump inhibitors exacerbate NSAID-induced small intestinal injury by inducing dysbiosis. Gastroenterology, 141 (4), 1314–1322, 1322.e1–5.
   PubMed Web of Science ®Google Scholar
• Wang, J., et al., 2013. Inhibition of protease-activated receptor 1 ameliorates intestinal radiation mucositis in a preclinical rat model. International journal of radiation oncology biology physics, 85 (1), 208–214.
   PubMed Web of Science ®Google Scholar
• Watanabe, S., et al., 1998. Effects of teprenone on gastric epithelial restoration in a rabbit cultured cell model. Journal of gastroenterology, 33 (2), 153–159.
   PubMed Web of Science ®Google Scholar
• Xiong, L., et al., 2015. Geranylgeranylacetone protects against small-intestinal injuries induced by diclofenac in patients with rheumatic diseases: a prospective randomized study. Digestive and liver disease : disease, 47 (4), 280–284.
   Web of Science ®Google Scholar
• Xu, Q.L., et al., 2015. Blockage of protease-activated receptor 1 ameliorates heat-stress induced intestinal highpermeability and bacterial translocation. Cell biology international, 39 (4), 411–417.
   PubMed Web of Science ®Google Scholar
• Zhang, S., Chao, G.Q., and Lu, B., 2013. Proton pump inhibitors are not the key for therapying non-steroidal anti-inflammatory drugs-induced small intestinal injury. Rheumatology international, 33 (10), 2513–2521.
   PubMed Web of Science ®Google Scholar